Nature's Sunshine Products, Inc. Stock

Equities

NATR

US6390271012

Food Processing

Market Closed - Nasdaq 04:00:00 2024-05-31 pm EDT 5-day change 1st Jan Change
15.32 USD +1.06% Intraday chart for Nature's Sunshine Products, Inc. -0.71% -11.39%
Sales 2024 * 456M Sales 2025 * 483M Capitalization 287M
Net income 2024 * 13M Net income 2025 * 16M EV / Sales 2024 * 0.43 x
Net cash position 2024 * 90.2M Net cash position 2025 * 99M EV / Sales 2025 * 0.39 x
P/E ratio 2024 *
21.3 x
P/E ratio 2025 *
17.8 x
Employees 814
Yield 2024 *
-
Yield 2025 *
-
Free-Float 78.79%
More Fundamentals * Assessed data
Dynamic Chart
Tranche Update on Nature's Sunshine Products, Inc.'s Equity Buyback Plan announced on March 10, 2021. CI
Transcript : Nature's Sunshine Products, Inc., Q1 2024 Earnings Call, May 07, 2024
Earnings Flash (NATR) NATURE'S SUNSHINE PRODUCTS Reports Q1 GAAP EPS $0.12, vs. Street Est of $0.17 MT
Earnings Flash (NATR) NATURE'S SUNSHINE PRODUCTS Reports Q1 Revenue $111M, vs. Street Est of $111.2M MT
Nature's Sunshine Products, Inc. Provides Earnings Guidance for the Full Year 2024 CI
Nature's Sunshine Products, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
DA Davidson Raises Nature's Sunshine Products' Price Target to $24 From $21.50, Maintains Buy Rating MT
Tranche Update on Nature's Sunshine Products, Inc.'s Equity Buyback Plan announced on March 10, 2021. CI
Nature's Sunshine Products, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Nature's Sunshine Products, Inc., Q4 2023 Earnings Call, Mar 12, 2024
Earnings Flash (NATR) NATURE'S SUNSHINE PRODUCTS Reports Q4 EPS $0.45 MT
Earnings Flash (NATR) NATURE'S SUNSHINE PRODUCTS Posts Q4 Revenue $108.9M, vs. Street Est of $111.1M MT
Nature's Sunshine Products, Inc. Provides Earnings Guidance for the Full Year 2024 CI
Nature's Sunshine Products, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Natures Sunshine Products Insider Sold Shares Worth $256,960, According to a Recent SEC Filing MT
More news

Latest transcript on Nature's Sunshine Products, Inc.

1 day+1.06%
1 week-0.71%
1 month-21.23%
3 months-13.69%
6 months-10.57%
Current year-11.39%
More quotes
1 week
14.99
Extreme 14.99
15.51
1 month
13.92
Extreme 13.92
19.79
Current year
13.92
Extreme 13.92
21.72
1 year
11.15
Extreme 11.15
21.72
3 years
7.93
Extreme 7.93
21.72
5 years
5.50
Extreme 5.5
21.72
10 years
5.50
Extreme 5.5
21.72
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 18-09-24
Director of Finance/CFO 53 22-12-18
Sales & Marketing 41 23-10-29
Members of the board TitleAgeSince
Chairman 66 18-05-24
Director/Board Member 53 17-06-07
Chief Executive Officer 61 18-09-24
More insiders
Date Price Change Volume
24-05-31 15.32 +1.06% 44,382
24-05-30 15.16 +0.80% 43,400
24-05-29 15.04 -1.31% 105,326
24-05-28 15.24 -1.23% 162,863
24-05-24 15.43 +0.19% 32,207

Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT

More quotes
Nature's Sunshine Products, Inc. is a natural health and wellness company, which markets and distributes nutritional and personal care products in more than 40 countries. The Company sells its products to a sales force of independent consultants who use the products themselves or resells them to consumers. The Company has four segments: Asia, Europe, North America, and Latin America and Other. Each of the geographic segments operates under the Natures Sunshine Products and Synergy WorldWide brands. The Latin America and Other segment include its wholesale business, in which the Company sells products to various locally managed entities, independent of the Company, that it has granted distribution rights for the relevant market. The Company's line of over 800 products includes several different product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. It purchases herbs and other raw materials in bulk.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
15.32 USD
Average target price
23 USD
Spread / Average Target
+50.13%
Consensus